Israeli scientist named Beka Solomon, a professor at Tel Aviv University, made a serendipitous discovery one day when she was testing a new class of agents against Alzheimer’s disease. If it pans out, ...
Gensaic enters into collaboration to develop phage-derived gene therapies for central nervous system
Gensaic to collaborate exclusively with Ovid Therapeutics to develop up to three genetic medicines for CNS indications using its proprietary phage-derived particle (PDP) platform; terms are currently ...
The 8th International Winter Conference on Alzheimer’s Disease, held 7-10 December 2012 in Zuers, Austria, featured alternative treatment approaches that are trying to reach the starting line for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results